Article Versions Notes

Islam SMBU, Hong YM, Ornella MsC, Ngabire D, Jang H, Cho E, Kim E-K, Hale JJJ, Kim CH, Ahn SC, et al. Engineering and Preclinical Evaluation of Western Reserve Oncolytic Vaccinia Virus Expressing A167Y Mutant Herpes Simplex Virus Thymidine Kinase. Biomedicines. 2020; 8(10):426. https://doi.org/10.3390/biomedicines8100426

Islam, S. M. Bakhtiar UL, Young Mi Hong, Mefotse saha Cyrelle Ornella, Daniel Ngabire, Hyunjung Jang, Euna Cho, Eung-Kyun Kim, Jessye Jin Joo Hale, Cy Hyun Kim, Soon Cheol Ahn, and et al. 2020. "Engineering and Preclinical Evaluation of Western Reserve Oncolytic Vaccinia Virus Expressing A167Y Mutant Herpes Simplex Virus Thymidine Kinase" Biomedicines 8, no. 10: 426. https://doi.org/10.3390/biomedicines8100426

Islam, S. M. B. U., Hong, Y. M., Ornella, M. s. C., Ngabire, D., Jang, H., Cho, E., Kim, E.-K., Hale, J. J. J., Kim, C. H., Ahn, S. C., Cho, M., & Hwang, T.-H. (2020). Engineering and Preclinical Evaluation of Western Reserve Oncolytic Vaccinia Virus Expressing A167Y Mutant Herpes Simplex Virus Thymidine Kinase. Biomedicines, 8(10), 426. https://doi.org/10.3390/biomedicines8100426